About

About Quanttrace Quanttrace: Pioneering Non-Invasive Therapeutic Drug Monitoring Quanttrace is a spin-off from the Laboratory of Neuroengineering at the National University of San Martín (UNSAM, Buenos Aires, Argentina). We are pioneers in non-invasive therapeutic drug monitoring, developing devices that personalize healthcare without interfering with patients' daily lives. Successful pharmacological treatment relies on patient adherence. However, even perfect adherence can't prevent plasma level variability due to individual differences in absorption, metabolism, and sensitivity. Personalized medicine aims for optimal drug levels tailored to each individual, especially for medications with narrow therapeutic ranges (such as oncologic drugs, antipsychotics, anticonvulsants, and antibiotics). Our challenge at Quanttrace is to provide the pharmaceutical and biotech industries with in-situ methods for measuring plasma concentrations without disrupting daily routines. Our technology is wearable, non-invasive, and works in everyday environments without laboratory equipment. Data is processed on a mobile device, and results are immediate. Quanttrace merges complex signal analysis and AI tools with advanced medicinal chemistry, allowing patients and caregivers to monitor plasma drug concentration at home and communicate directly with their doctors. This represents a significant advancement towards precision medicine and in-situ dose control, ensuring optimal treatment adherence. At Quanttrace we are currently conducting preclinical trials in small and large animals to validate our technology. At this stage, we have filed a provisional patent to protect our innovation. Right now we are actively seeking investment to refine our development and successfully conclude our preclinical trials and go into a clinical phase of research. We are open to hearing from investors who wish to partner with us in this innovative and exciting research pipeline. keywords: personalized medicine, precision medicine, precision healthcare, patient monitoring device, in-situ dose control, therapeutic drug monitoring, artificial intelligence, AI, medicinal chemistry, at home monitoring.